Veterinary Oxygen Therapy Market Size & Share 2025 - 2034
Market Size by Product, by Animal Type, by Application.
Download Free PDF
Market Size by Product, by Animal Type, by Application.
Download Free PDF
Starting at: $2,450
Base Year: 2024
Companies Profiled: 11
Tables & Figures: 162
Countries Covered: 19
Pages: 140
Download Free PDF
Veterinary Oxygen Therapy Market
Get a free sample of this report
Veterinary Oxygen Therapy Market Size
The global veterinary oxygen therapy market was valued at USD 1.2 billion in 2024. The market size is estimated to grow from USD 1.3 billion in 2025 to USD 2.7 billion in 2034, growing at a CAGR of 8.5% from 2025 to 2034. This growth is primarily attributed to the growing incidence of diseases such as pneumonia and chronic obstructive pulmonary disease (COPD) in animals, coupled with post-surgical recovery complications, which have significantly increased the demand for oxygen therapy in veterinary care.
Veterinary Oxygen Therapy Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The needs of older pets, along with problems related to pollution, obesity, and other related respiratory issues, further increase this need. Veterinary clinics and hospitals are using oxygen concentrators, high-efficiency masks, and nasal catheters to improve treatment results for these conditions.
Technological advancements is one of the factors contributing to the expansion of the veterinary oxygen therapy market by improving efficiency, portability, and treatment outcomes. The introduction of new portable oxygen concentrators helps in giving continuous oxygen, allowing veterinarians to treat animals at home and reducing the need for hospitalization. Additionally, the advancement of high-efficiency oxygen masks, humidifiers, and nasal catheters have improved patient comfort and oxygen absorption, especially in critical care and after surgery, leading to more demand for veterinary oxygen concentrators and related equipment.
Furthermore, increasing rates of pet ownership have also served as an important driver for the market. For instance, according to Health for Animals in 2022, the global pet population was more than one billion. Additionally, in the U.S., around 66% of households have pets, as reported by the American Pet Products Association (2023-2024), which has increased the need for basic veterinary services and emergency treatments, including oxygen therapy that needs concentrators and other equipment.
Also, pet insurance has helped market growth by making advanced medical treatments, like oxygen therapy, easier to afford and access. The growth of veterinary emergency and critical care services has also helped the market grow. Many veterinary hospitals now offer 24-hour oxygen therapy support, which helps more pets survive when they have breathing problems, injuries, or problems after surgery. This increased availability has created more demand for oxygen concentrators, masks, humidifiers, and nasal catheters.
The market includes special medical equipment made to give extra oxygen to animals. It is majorly used for animals suffering from respiratory distress, hypoxia (low blood oxygen levels), or other conditions requiring oxygen support. Oxygen concentrators and accessories are commonly used in veterinary clinics, hospitals, and emergency settings.
Veterinary Oxygen Therapy Market Trends
Veterinary Oxygen Therapy Market Analysis
Based on the product, the global veterinary oxygen therapy market is segmented into veterinary oxygen concentrator and accessories. The veterinary oxygen concentrator segment dominated the market and was valued at USD 984.5 million in 2024. The veterinary oxygen concentrator segment is further sub-segmented into stationary oxygen concentrator and portable oxygen concentrator.
Based on animal type, the global veterinary oxygen therapy market is categorized into small animals and large animals. The small animals segment held the highest market share of 60% in 2024.
Based on the application, the global veterinary oxygen therapy market is classified into intensive care, homecare setting/ postoperative care, and other applications. The intensive care segment is expected to witness growth at 8.4% CAGR over the analysis period and reach USD 1.8 billion by 2034.
Based on the end use, the global veterinary oxygen therapy market is divided into veterinary hospitals, veterinary clinics, and other end users. The veterinary hospitals segment in 2024 was valued at USD 568.6 million and is expected to reach USD 1.3 billion by the end of the forecast timeframe.
The North America veterinary oxygen therapy market dominated the global market with a market share of 39.9% in 2024.
The U.S. market was valued at USD 364.9 million in 2021. In 2023, the U.S. dominated the North America market with a revenue of USD 413 million growing from USD 387.9 million in 2022.
Germany veterinary oxygen therapy market is anticipated to witness considerable growth in the Europe market over the analysis period.
India veterinary oxygen therapy market is anticipated to witness high growth in Asia Pacific market.
In Latin America, Brazil veterinary oxygen therapy market is anticipated to experience significant growth in coming years.
In Middle East and Africa, Saudi Arabia veterinary oxygen therapy market is poised to witness rapid growth over the analysis period.
Veterinary Oxygen Therapy Market Share
The market is witnessing a surge in competition, as several major players focus on gaining additional market share through new technologies, partnerships, and geographical expansions. Top 5 players in this market including Vetland Medical, CAIRE, Longfian Scitech, RWD Life Science, and Drive DeVilbiss accounted for approximately 20 - 25% of market share. These players are focusing on higher spending on R&D to improve efficiency in oxygen delivery, as well as to miniaturize and enhance the portability of the equipment. In addition, strategic partnerships, acquisitions, and collaborations with veterinary clinics and hospitals are often employed to broaden market access.
Veterinary Oxygen Therapy Market Companies
Some of the prominent players operating in the veterinary oxygen therapy industry include:
Renowned for high-quality oxygen therapy equipment, CAIRE provides reliable oxygen concentrators like the AirSep series, known for their efficiency and durability in both human and veterinary applications. The company's advanced oxygen solutions ensure consistent, high-purity oxygen delivery, supporting veterinary clinics, hospitals, and critical care units worldwide.
Shinova’s veterinary oxygen concentrators stand out for their durability, safety, and advanced technology. Designed with a full plastic shell for a sleek appearance, they feature built-in safety valves, power failure alarms, and high-purity oxygen delivery using USA-imported molecular sieves. Their CPU-controlled system with Motorola pressure sensors ensures precision, reliability, and seamless veterinary care.
Veterinary Oxygen Therapy Industry News
The veterinary oxygen therapy market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Animal Type
Market, By Application
Market, By End Use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →